We’re committed to advancing cardiology through less invasive technologies that improve outcomes, deliver care to more patients, reduce costs, and help millions live healthier lives.
Delivering Meaningful Innovation
Life Changing Stroke Risk Treatment Option. WATCHMAN™ Left Atrial Appendage Closure Device offers patients with non-valvular atrial fibrillation a potentially life-changing stroke risk treatment option which could free them from the burden of long-term warfarin therapy. The WATCHMAN Left Atrial Appendage Closure Device is a proven one-time procedure that reduces the risk of stroke in your non-valvular atrial fibrillation (NVAF) patients and the risk of bleeding that comes with a lifetime of oral anticoagulant use.The SYNERGY™ System is a new category of stent designed to promote healing and its bioabsorbable polymer coating is gone when it's no longer needed, shorty after the drug is completely eluted at 3 months. The SYNERGY stent continues to improve patient's lives, even in more complex cases.
First of It's kind TAVI Portfolio. Based on the belief that no single valve is ideal for all patients and that growth of the TAVI therapy will require more options, Boston Scientific has invested in two different but complementary valve technologies. ACURATE neo™ and LOTUS Edge™ Aortic Valve Systems are different in terms of expansion mechanism, sealing mechanism, leaflet material and leaflet position. They also offer different access options. With two valves, Boston Scientific can offer a simplified approach to managing TAVI, with the technologies needed to thoughtfully tailor treatment to each patient.
Conditions We Treat
Solutions We Offer